Participation in cancer screening among people living with HIV at a university hospital

Pei-Ying Wu; Hsin-Yun Sun; Mao-Yuan Chen; Wang-Huei Sheng; Szu-Min Hsieh; Yu-Chung Chuang; Hsi-Yen Chang; Yu-Zhen Luo; Jun-Yu Zhang; Chien-Ching Hung

doi:10.1016/j.jmii.2021.04.004

Participation in cancer screening among people living with HIV at a university hospital

J Microbiol Immunol Infect. 2022 Feb;55(1):161-165. doi: 10.1016/j.jmii.2021.04.004. Epub 2021 Apr 28.

Authors

Affiliations

¹ Center of Infection Control, National Taiwan University Hospital, Taipei, Taiwan.
² Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.
³ Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan; Department of Tropical Medicine and Parasitology, National Taiwan University College of Medicine, Taipei, Taiwan; Department of Medical Research, China Medical University Hospital, Taichung, Taiwan; China Medical University, Taichung, Taiwan. Electronic address: hcc0401@ntu.edu.tw.

PMID: 33965343
DOI: 10.1016/j.jmii.2021.04.004

Abstract

Between March and October, 2018, 1248 people living with HIV completed questionnaire interviews for cancer screening, of whom 46.9% (n = 585) completed free-of-charge cancer screening. Time constraint (50.1%) was the most common reason provided for refusal to participate in cancer screening. None of the participants were diagnosed with any of the four cancers.

Keywords: Combination antiretroviral therapy; Life expectancy; Mortality; Non-AIDS malignancy.

MeSH terms

Early Detection of Cancer
HIV Infections* / complications
HIV Infections* / diagnosis
HIV Infections* / epidemiology
Hospitals, University
Humans
Neoplasms* / diagnosis
Surveys and Questionnaires